Richard Gordon

Associate Professor Richard Gordon is affiliated with the School of Biomedical Sciences at Queensland University of Technology (QUT), leading a multi-disciplinary translational neuroscience research program focused on neurodegenerative diseases like Parkinson’s and ALS. His work integrates immunology, drug development, and microbial metagenomics to target disease mechanisms. He holds a Doctor of Philosophy and currently accepts research students at Honours, Masters, and PhD levels.

Research interests include chronic immune activation, gut dysbiosis in neurodegenerative disorders, and gut-brain axis therapies. Key projects address drug discovery, biomarker validation, and clinical trial development. Collaborations with industry partners advance translational outcomes. No awards are explicitly listed, though his publications reflect significant contributions to neuroinflammation and therapeutics. His program emphasizes clinical translation of findings from patient studies and disease models.

Publications span 2018–2023, focusing on inflammasome inhibition, drug repositioning (e.g., RRx-001), and neuroprotective strategies. Supervision and mentoring are central to his role, with active recruitment for innovative projects. His research infrastructure includes partnerships supporting biomarker discovery and therapeutic development.